🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jonathan H. Shrimp

National Center for Advancing Translational Sciences

ORCID: 0000-0001-9872-942X

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

3.3Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Real-time sharing of drug screening data on the NCATS OpenData Portal accelerates translational research

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.04.135046

Top 7%

3.3DataRank

Top 7%108 citations

Tongan Zhao, Richard T. Eastman, Xin Hu, Ke Wang, Mark Backus +31 more

Papers

Driven by 14 papers — median percentile 93. Top paper: “Real-time sharing of drug screening data on the NCATS OpenData Portal accelerates translational research”.

Real-time sharing of drug screening data on the NCATS OpenData Portal accelerates translational research

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.04.135046

Top 7%

3.3DataRank

Top 7%108 citations

Tongan Zhao, Richard T. Eastman, Xin Hu, Ke Wang, Mark Backus +31 more

Remodelin Is a Cryptic Assay Interference Chemotype That Does Not Inhibit NAT10-Dependent Cytidine Acetylation

ACS Medicinal Chemistry Letters(2020)10.1021/acsmedchemlett.0c00193

N/A

1.7DataRank · unranked

36 citations

Yihang Jing, Supuni Thalalla Gamage, Kathryn M. Nelson, Joseph Han, Keri M. Bryson +17 more

High-resolution acoustic ejection mass spectrometry for high-throughput library screening

SLAS TECHNOLOGY(2024)10.1016/j.slast.2024.100199

N/A

0.360DataRank · unranked

10 citations

D. Calabrese, Zina Itkin, Glenn Gomba, Min Shen, Meghav Verma +9 more

Reference compounds for characterizing cellular injury in high-content cellular morphology assays

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.07.12.499781

N/A

0.104DataRank · unranked

1 citations

Bruce K. Hua, Beth E. Zucconi, Shawn D. Nelson, Shantanu Singh, Anne E. Carpenter +21 more

SULT1A1-dependent sulfonation of alkylators is a lineage-dependent vulnerability of liver cancers

Nature Cancer(2023)10.1038/s43018-023-00523-0

N/A

0DataRank · unranked

25 citations

William Shen, Mindy I. Davis, Ke Kong, Phuong Vu, Supriya K. Saha +34 more

Methotrexate-based PROTACs as DHFR-specific chemical probes

Cell chemical biology(2023)10.1016/j.chembiol.2023.09.014

N/A

0DataRank · unranked

20 citations

Patricia Dranchak, Jayme L. Dahlin, Laurence Lamy, Wenqing Li, Erin Oliphant +12 more

Nonspecific membrane bilayer perturbations by ivermectin underlie SARS-CoV-2 in vitro activity

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.23.563088

N/A

0DataRank · unranked

4 citations

Radda Rusinova, Karl F. Herold, Xi‐Ping Huang, Patricia Dranchak, Ty C. Voss +9 more

Notes on AEMS methods development for high throughput experimentation in drug discovery

SLAS TECHNOLOGY(2024)10.1016/j.slast.2024.100234

N/A

0DataRank · unranked

2 citations

Nate Hoxie, John Janiszewski, Charles Bonney, Matthew D. Hall, Sam Michael +3 more

SAR Studies around the SULT1A1-Activated Alkylator YC-1 as Cytotoxic Agents against Biliary Tract Cancer Cells

Journal of Medicinal Chemistry(2025)10.1021/acs.jmedchem.5c00489

N/A

0DataRank · unranked

0 citations

Wei Zhao, Jonathan H. Shrimp, Marius Vava, Rohan Sinha, Shweta Sharma +17 more

Dynamic Imaging of LDH Inhibition in Tumors Reveals Rapid In Vivo Metabolic Rewiring and Vulnerability to Combination Therapy

Cell Reports(2020)10.1016/j.celrep.2020.01.039

N/A

0DataRank · unranked

125 citations

Ryo Ishida, Shun Kishimoto, Kristin Beebe, Jeffrey Brender, Kazutoshi Yamamoto +36 more

Mass spectrometry-guided discovery of novel GCPII inhibitor scaffolds

Frontiers in Pharmacology(2025)10.3389/fphar.2025.1646207

N/A

0DataRank · unranked

0 citations

Ajit G. Thomas, John Janiszewski, Nate Hoxie, Chae Bin Lee, Ying Wu +13 more

Discovery of TMPRSS2 inhibitors from virtual screening

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.12.28.424413

N/A

0DataRank · unranked

8 citations

Jonathan H. Shrimp, Hui Guo, Miao Xu, Catherine Z. Chen, Wei Zhu +7 more

Suite of TMPRSS2 Assays for Screening Drug Repurposing Candidates as Potential Treatments of COVID-19

ACS Infectious Diseases(2022)10.1021/acsinfecdis.2c00172

N/A

0DataRank · unranked

8 citations

John Janiszewski, Catherine Z. Chen, Miao Xu, Kelli M. Wilson, Stephen C. Kales +12 more

Reference compounds for characterizing cellular injury in high-content cellular morphology assays

Nature Communications(2023)10.1038/s41467-023-36829-x

N/A

0DataRank · unranked

42 citations

Bruce K. Hua, Beth E. Zucconi, Shawn D. Nelson, Shantanu Singh, Anne E. Carpenter +21 more